Biothreats Banner black 1230x300

Submit Abstracts

Abstract submission for the 2018 ASM Biothreats meeting is now closed!  

The expanded 2018 Biothreats Program Committee is leading the way this year to revitalize the 2018 program with more cutting-edge science, research, and networking opportunities; and they are seeking your innovative research findings and discoveries for you to share with experts from around the world. Submit an abstract and contribute to the discussions that will shape the future of this important field. 

Students and early career scientists are also eligible for an ASM Biothreats Travel Award when submitting an abstract! Get the funding you need to assist in your participation at this premier event! 

Important Dates

Abstract submission opens: September 11, 2017

Abstract submission closes: November 10, 2017, 5:00 p.m. ET

Oral Presentation Opportunities

In an effort to increase opportunities for students, post-doctoral, and early career professionals to present their basic science and policy research, the ASM Biothreats meeting has established a free, half-day Pre-Meeting Symposium on Sunday, February 11, tailored specifically for peer-to-peer engagement.

Interested individuals must submit an abstract for consideration no later than November 10, 2017, 5:00 p.m. ET. After submitting an abstract, a request form must be submitted by November 10, 2017, 5:00 p.m. ET to be considered for the symposium. 

All notifications of accepted oral and/or poster presentations, including those accepted for the symposium will be sent on or before December 1, 2017. Abstracts not accepted for oral presentation during the symposium may still be selected for poster presentation during the Biothreats meeting.

Submission Steps

Step One: Login

Please use your ASM Single Sign On (SSO) login credentials. If you forgot your username/password or to confirm that you have a Single Sign On (SSO) account, press the "Forgot Username and/or Password?" link on the homepage of the submission site. If you do not have an ASM Single Sign On (SSO) account, you may create one by following the link on the homepage of the submission site.

Step Two: New Abstract

Click the "New Abstract" button to begin the abstract submission process.

Step Three: Affirmations

In order to proceed with the abstract submission, your agreements with the following statements are required.

  • All authors are aware that their names appear on this abstract.
  • I understand that if this abstract is accepted, ASM will hold the Copyright.
  • I understand that if this abstract is withdrawn after November 6, 2017, or one of the authors does not appear to present an accepted abstract, or a change in the presenting author is not communicated to ASM, a penalty will be incurred prohibiting the presenting author from presenting papers at ASM-sponsored meetings for a period of three years.
  • This abstract is based on results that have not, nor will have been, published in any journal, book, and/or website prior to February 14, 2018, or presented at any public scientific conference prior to February 14, 2018.
  • Content for this activity, including any presentation of therapeutic options, will be well-balanced, evidence-based and unbiased.
  • If I am presenting research funded by a commercial company, the information presented will be based on generally accepted scientific principles and methods, and will not promote the commercial interest of the funding company.
  • The content and/or presentation of the information with which I am involved will promote quality or improvements in health care and will not promote a specific proprietary business interest of a commercial interest.
  • I have not accepted any honoraria, additional payments or reimbursements beyond that which has been agreed upon directly with ASM. 
  • I understand that my presentation will be monitored to be sure that it is educational and not commercial in nature.
  • If I am providing recommendations involving clinical medicine, they will be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
  • If I am discussing specific health care products or services, I will use generic names to the extent possible. If I need to use trade names, I will use trade names from several companies when available, and not just from any single company.
  • If I am discussing any product use that is off label, I will disclose that the use or indication in question is not currently approved by the FDA for labeling or advertising.
  • If I have been trained or utilized by a commercial entity or its agents as a speaker (e.g., speaker's bureau) for any commercial interest, the promotional aspects of that presentation will not be included in any way with this activity.

Step Four: Title (included in the 2,000 character limit; spaces are not counted)

Please use a short and concise title that indicates the content of the abstract. Capitalize the first letter of each word except prepositions, articles and species names. Italicize scientific names of organisms by highlighting the term and clicking the online format tool bar for italics. Trade names are not permitted in abstract titles.

Click the "Save and Continue" button.

Step Five: Track

For purposes of review and programming, abstracts are also divided into tracks. Selection of the most appropriate track is important as it determines who reviews your abstract. Please read each track title to ensure that your abstract fits the track you select. The Biothreats Program Committee reserves the right to reassign your abstract to a more appropriate track. Abstract tracks are:

  • High Consequence Pathogen Research
  • Product Development
  • Policy
  • Biological Threat Reduction

When provided with funding, the ASM allows students or early career professionals the opportunity to be considered for a travel award. At this point you will also be asked if you are a student or early career professional. If you are, you will then be asked if you would like to be considered for a travel award.

Click the "Save and Continue" button.

Step Six: Category

For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. Please carefully read the list of Topical Categories to ensure that your abstract fits the category you select. The Biothreats Program Committee reserves the right to reassign your abstract to a more appropriate category. Abstract categories are:

  1. Viral Agents
  2. Bacterial Agents
  3. Fungal Agents
  4. Diagnostics
  5. Environmental Detection
  6. Information and Genomics
  7. Therapeutics
  8. Vaccines
  9. Immune Response
  10. Decontamination, Biosafety, and Containment
  11. Other and Information Only

Click the "Save and Continue" button.

Step Seven: Keywords

Keywords are completely independent of each other and should be able to stand alone in the index. Words should be lowercase, except for genus names and proper nouns. For Greek characters, please spell out names. Organisms will be italicized in final publications. One keyword is required.

Click the "Save and Continue" button.

Step Eight: Primary Author

Authors, groups and institutions are included in the 2,000 character limit; spaces are not counted. Author's names will be displayed using first initial(s) and full last name. Presenting authors will be displayed in bold type (e.g. J. Smith, W. S. Brown, and R. A. Jones). Each institution and author will be referenced with superscript numbers and include the institution, city, two-letter state/province abbreviation and country.
ASM will correspond with the presenting author only. Changes in the presenting author must be communicated to ASM. It is the responsibility of the presenting author to contact all co-authors with the disposition and scheduling of the abstract.
Click the "Save and Continue" button.

Step Nine: Co-Authors, Groups, Additional Institutions

Click "Add a Group" or "Add an Author" for each co-author or group. Institutions should be entered for each author. If you wish to add multiple institutions for an author, click the "Add Institution" link below the respective author's name.

Click the "Save and Continue" button.

Step Ten: Abstract Text

Your abstract may have up to 2,000 characters, which include title, authors, institutions, abstract text, tables and images. Spaces are not counted. Do not include abstract title, authors or keywords in abstract text. Abstract text may be submitted using either of the following methods: Copy/paste or direct entry keystrokes. Each table or image reduces the character count by 250 characters. Once your abstract text is saved, you will be given the opportunity to add an image or table.


  • The recommended table size is 5 columns by 8 rows
  • Table Generator: Limit of 5 columns and 8 rows. Use tab to move between cells. Online instructions are available as you proceed.
  • You may also update your table as an image.


  • Supported formats are limited to GIF and JPG files.
  • The recommended graphic size, to optimize resolution, is 2 inches wide by 3 inches tall and 300 DPI.
  • Are submitted separately, subsequent to abstract text
  • Will appear large on screen, but will be adapted for publication

Click the "Save and Continue" button.

Step Eleven: Review Your Work

It is very important that you review your work to proof accuracy of all elements of the submitted abstract including spelling and figures. Ensure that the character count is within the 2,000 character limit and that all submitted tables and graphics are completely submitted and appear in the abstract text to guarantee that the abstract submission process is complete.

Technical Support

If you have any questions regarding use of the abstract submission site please contact technical support: 

Email: | Phone: (217) 398-1792 Fax: (217) 355-0101

Abstract Review Process

All abstracts submitted to the 2018 ASM Biothreats for consideration will be reviewed by at least one member of the Program Committee. The Committee will determine if the abstract merits inclusion in the program and, if accepted, will schedule the abstract in the appropriate session for the meeting. An abstract may be rejected for one or more of the following reasons. All decisions relating to acceptance or rejection are final.

  1. No Background or Hypothesis - The abstract does not clearly indicate the reason for conducting the research or the question being tested by the experiments performed.
  2. Inadequate Experimental Methods - The investigators failed to describe procedures used or neglected to include important or essential controls.
  3. Insufficient Data Presented - The investigators failed to show the outcome(s) of their research. Insufficient data are presented to support the authors' conclusion(s).
  4. No Summary Form of Essential Results - The investigators failed to concisely summarize the result(s) of their research.
  5. No Conclusion - The investigators failed to describe the conclusions of their research with regard to the hypothesis being tested.
  6. Duplicate Abstract - The abstract contents substantively overlap with contents of another submitted abstract by the same author or co-author. Reviewers may elect to accept a single abstract and suggest that the authors consolidate their material.
  7. Not appropriate for the Biothreats meeting- The content of the abstract is not relevant to the defined goals of the Biothreats meeting
  8. Promotional in Nature - The abstract was written to promote a specific product or procedure on behalf of a specific company or organization.
  9. Poorly Written - Improper use of the English language renders the abstract incomprehensible.
  10. Duplicate Presenting Author - An author can be the presenting author on only one abstract.


Abstract disposition notices will be made available through email notification to presenting authors only the week of November 13-17, 2017. It is the responsibility of the presenting author to inform all co-authors of disposition status and accepted abstract scheduling information. If you have not received notification by November 21, 2017, please email to have a disposition notice resent.

Withdrawals and Penalties

If an abstract must be withdrawn, the author must send a letter of explanation to ASM at If an accepted abstract is published prior to 2018 ASM Biothreats the authors agree to withdraw the abstract. Withdrawals of abstracts made after December 4, 2017, can be subject to a penalty as described below.

Persons who submit abstracts should consider them official communication to the conference. The following cases can incur a penalty, prohibiting the author from presenting papers at ASM meetings and conferences for up to three years. A letter will be mailed to individuals being subject to this penalty. Those who wish to dispute the penalty must write a letter to the Biothreats Program Committee and send it to the attention of the Biothreats Program Assistant at A response letter will be sent to the presenting author once the committee has considered and acted on your exception request.

Cases subject to penalty:

  • Submission of an abstract based on results that have been published in any journal, or on any web site before February 14, 2018; or presented or submitted for presentation at any public scientific conference prior to February 14, 2018.
  • Withdrawal of an abstract after the December 4, 2018 deadline.
  • Failure of any of the co-authors to present an accepted abstract as scheduled.
  • Use of a slide or poster presentation for promotional purposes.
  • Presentation of an un-authorized abstract.
  • Failure to notify ASM of a change in the presenting author.

Abstracts Dealing with Microbiological Sensitive Issues

The Council Policy Committee of the American Society for Microbiology affirms the long-standing position of the Society that microbiologists will work for the proper and beneficent application of science and will call to the attention of the public or the appropriate authorities' misuses of microbiology or of information derived from microbiology. ASM members are obligated to discourage any use of microbiology contrary to the welfare of humankind, including the use of microbes as biological weapons. Bioterrorism violates the fundamental principles expressed in the Code of Ethics of the Society and is abhorrent to the ASM and its members.